-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.O2.6 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Treatment-Free Remission and Prognostication Clinically Relevant Abstract

Symposia: Chronic Myeloid Leukemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Clinical Research, health outcomes research, CML, Chronic Myeloid Malignancies, Diseases, Myeloid Malignancies
Sunday, December 10, 2023: 9:30 AM-11:00 AM
Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
Moderators:
Francois Mahon, MD, PhD, Universite Bordeaux 2 and Mhairi Copland, PhD, MBBChir, FRCP, FRCPath, Gartnavel General Hospital
Disclosures:
Copland: Incyte: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Pfizer: Honoraria, Speakers Bureau; Astellas: Honoraria, Speakers Bureau; Jazz: Honoraria, Membership on an entity's Board of Directors or advisory committees; Servier: Honoraria, Membership on an entity's Board of Directors or advisory committees.
9:30 AM

Franck E. Nicolini, MD, PhD1,2, Aude Charbonnier, MD, PhD2,3*, Martine Escoffre-Barbe, MD2,4*, Eric Jourdan, MD, PhD2,5*, Gabrielle Roth-Guepin, MD2,6*, Marc G. Berger, MD, PhD2,7*, Shanti Amé, MD2,8*, Marion Simonet, MD2,9*, Hyacinthe A. Johnson-Ansah, MD2,10*, Viviane Dubruille, MD2,11*, Amandine Charbonnier, MD2,12*, Philippe Rousselot, MD, PhD2,13*, Corentin Orvain2,14*, Bertrand Joly, MD2,15*, Jean-Christophe Ianotto, MD, PhD2,16*, Emilie Cayssials, MD, PhD2,17*, Mathieu Meunier, MD, PhD2,18*, Anne Parry, MD2,19*, Valerie Coiteux, MD2,20*, Laurence Legros, MD, PhD2,21*, Hacene Zerazhi, MD2,22*, Gabriel Etienne, MD, PhD2,23*, Philippe Quittet, MD2,24*, Ollivier Legrand, MD25*, Amelie Penot, MD2,26*, Lydia Roy, MD2,27*, Ludovic Fouillet, MD28*, Stéphane Morisset, Biostat2,29*, Isabelle Tigaud, MD2,30*, Romaine Mayet, PhD31*, Gwenaëlle Garin, PhD31*, Jérôme Guitton, MD, PhD32*, Stéphanie Dulucq, PharmD, PhD2,33* and Françoise Huguet, M.D.2,34*

1Hematology department & CRCL INSERM U1052, Centre Léon Bérard, Lyon, France
2Centre Léon Bérard, Fi-LMC, Lyon, France
3Department of Hematology, Institut Paoli-Calmettes, Marseille, France
4Hematology department, Hôpital de Pontchaillou, Rennes, France
5Hematology department, Institut de Cancérologie du Gard, CHU de Nîmes, Nimes, France
6Department of clinical hematology, CHRU NANCY, Vandoeuvre Les Nancy, France
7Laboratoire d'Hématologie Biologique, CHU Estaing, Clermont-Ferrand, France
8Department of hematology, Institut de Cancérologie de Strasbourg Europe., Strasbourg, France
9Hematology department, Centre Hospitalier Universitaire, Besançon, France
10Caen University Hospital, Normandy, Hematology Institute, Caen, France
11Hematology dedpartment, Hôtel Dieu, CHU de Nantes, Nantes, France
12Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
13Hematology department, UMR1184, Centre Hospitalier de Versailles, University Paris-Saclay, Versailles, France
14Hematology Department, Angers University Hospital, Angers, France
15Hematology department, Centre Hospitalier Francilien Sud, Corbeil-Essonne, France
16Centre Hospitalier Universitaire de Brest,, Brest, France
17Hematology department, University Hospital Jean Bernard, Poitiers, France
18Clinique Universitaire d’hématologie, Université de Grenoble-Alpes, CHU de Grenoble, Grenoble, France
19Hematology department, Centre Hospitalier Annecy-Genevois, Pringy, France
20Hematology department, Centre Hospitalier Universitaire, Lille, France
21Hematology Department, AP-HP, University of Paris Saclay, Bicêtre Hospital, Paris, France
22Oncologie Médicale et Hématologie clinique, CH d'Avignon - Hôpital Henri Duffaut, Avignon, France
23Hematology department, Institut Bergonié, Bordeaux, France
24CHU Montpellier, Montpellier, France
25Hematology department, University Hospital Saint Antoine, Paris, France
26Department of hematology, Centre Hospitalier Universitaire Dupuytren, Limoges, France
27Hematology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
28Hematology department, CHU, Saint-Etienne, France
29Centre Léon Bérard, Lyon, France
30Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre Benite, France
31DRC, Centre Léon Bérard, Lyon, France
32Laboratoire de Biochimie et Toxicologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France
33Laboratory of Hematology, Hôpital Haut Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
34Hematology department, Institut Universaitaire du Cancer, CHU de Toulouse, Toulouse, France

9:45 AM

Andreas Hochhaus, MD1, Andreas Burchert, MD2, Susanne Saussele, MD 3, Gabriela M Baerlocher, MD4*, Jiří Mayer, MD5, Tim H. Brümmendorf6, Paul La Rosée, MD7*, Dominik Heim, MD8, Stefan W. Krause, MD9*, Philipp le Coutre, MD10*, Jenny Rinke, PhD11*, Thoralf Lange, MD12*, Alice Fabarius, PhD13*, Marcel Lorch3*, Mathias Hanel, MD14, Frank Stegelmann15*, Georg-Nikolaus Franke16*, Markus P. Radsak17*, Volker Kunzmann, MD18*, Daniela Zackova, MD5*, Danny Himsel, MSc11*, Denise Kohn19*, Thomas Lang, MSc19*, Rüdiger Hehlmann, MD 20, Christian Fabisch11*, Thomas Ernst, MD11 and Markus Pfirrmann, PhD19*

1Universitätsklinikum Jena, Jena, Germany
2Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
3Universitätsmedizin Mannheim, Mannheim, Germany
4Laboratory for Hematopoiesis and Molecular Genetics, University of Bern, Bern, Switzerland
5Masaryk University, Brno, Czech Republic
6Hematology/Oncology, Universitätsklinikum RWTH Aachen, Aachen, Germany
7Schwarzwald-Baar Klinikum, Villingen-Schwenningen, Germany
8Division of Hematology, University Hospital Basel, Basel, Switzerland
9Universitätsklinikum Erlangen, Erlangen, Germany
10Charité Humboldt Universität, Berlin, Germany
11Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany
12Hematology/Oncology, Asklepios Klinikum, Weißenfels, Germany
13Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
14Hematology/Oncology, Klinikum Chemnitz, Chemnitz, Germany
15Hematology/Oncology, Universitätsklinikum Ulm, Ulm, Germany
16Hematology, Universitätsklinikum Leipzig, Leipzig, Germany
17Hematology/Oncology, Universitätsmedizin Mainz, Mainz, Germany
18Medizinische Klinik II, Universitätsklinikum Wuerzburg, Wuerzburg, Germany
19Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, München, Germany
20ELN-Foundation, Weinheim, Germany

10:00 AM

Susan Branford, PhD1, Carol Wadham2*, Naranie Shanmuganathan, MBBS, FRACP, FRCPA, PhD3, Adelina Fernandes4*, Nur Hezrin Shahrin5*, Jinghua Feng6*, John Toubia7*, Paul Wang2*, Chung Hoow Kok, PhD, BSc8, Muneeza Maqsood9*, Verity Saunders10*, Rob King11*, Ming Lin6*, Rosalie Kenyon6*, Ilaria Stefania Pagani, PhD12*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA13, David M. Ross, MBBS, PhD, FRACP, FRCPA14*, Agnes S. M. Yong, MD, PhD8 and Timothy P Hughes, MD, MBBS, FRACP, FRCPA15

1Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia
2Centre for Cancer Biology, Adelaide, SA, AUS
3Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia
4University of Adelaide, Adelaide, Australia
5SA Pathology and Centre For Cancer Biology, Adelaide, AUS
6SA Pathology and Centre for Cancer Biology, Adelaide, AUS
7Centre For Cancer Biology, Adelaide, AUS
8Blood Cancer, Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
9Centre for Cancer Biology, Adelaide, Australia
10South Australian Health and Medical Research Institute (SAHMRI), Adelaide, AUS
11SA Pathology and Centre for Cancer Biology, Adelaide, Australia
12South Australian Health & Medical Research Institute (SAHMRI), Adelaide, AUS
13Haematology, Central Adelaide Local Health Network (CALHN), Adelaide, SA, Australia
14Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
15South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia

10:15 AM

Frederic Millot1*, Joe De Keizer2*, Markus Metzler, MD3*, Meinolf Suttorp4*, Petr Sedlacek, MD, PhD5*, Maaike Luesink6*, Frankie WT Cheng, MD7*, Krzysztof Kalwak8*, Birgitte Lausen9*, Gordana Jakovljevic10*, Barbara De Moerloose, MD11*, Michael Dworzak12*, Marina Borisevich13*, Julia Yajima14*, Mirella Ampatzidou15*, Roula Farah16*, Emilia Kaiserova17*, Adalet Meral Günes18* and Andre Baruchel19

1Inserm CIC 1402 - CHU Poitiers, Poitiers, France
2Inserm CIC 1402, Poitiers, France
3Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany
4Pediatric Hematology and Oncology, Medical Faculty, Technical University, Dresden, Germany
5Department of Pediatric Hematology–Oncology, University Hospital Motol, Charles University, Prague, Czech Republic
6Dutch Childhood Oncology Group, Princess Maxima Center for pediatric oncology, Princess Maxima Center for pediatric oncology, Utrecht, Netherlands
7Department of Pediatrics, Prince of Wales Hospital, Hong Kong, China
8Department of Pediatric Hematology Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland
9Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Denmark, Copenhagen, Denmark
10Department of Pediatric Hematology Oncology, Children’s Hospital, Zagreb, Croatia
11Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium
12St. Anna Children's Cancer Research Institute, Vienna, Austria
13Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
14Centro Infantil Boldrini, Sao Paulo, Brazil
15Department of Pediatric Hematology Oncology, Aghia Sophia Children’s Hospital, Athens, Greece
16Department of Pediatrics, LAU Medical Center Rizk Hospital, Beirut, Lebanon
17Department of Pediatric Oncology of University Children's Hospital, Bratislava, Slovakia
18Pediatric Hematology and Oncology Hospital Görükle, Bursa, Turkey
19Department of Pediatric Hematology, Robert Debré Hospital, Paris, France

10:30 AM

Susan Branford, PhD1, Andreas Hochhaus, MD2, Michael Mauro, MD3, Yosuke Minami, MD, PhD4, Delphine Rea, MD, PhD5, Carla Maria Boquimpani De Moura Freitas, MD6*, Pablo Serrano-Fernandez, PhD7*, Vanessa Obourn, MA8*, Andreas Bruederle, MD7*, Noemi Espurz, MS7* and Timothy P Hughes, MD, MBBS, FRACP, FRCPA9

1Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia
2Universitätsklinikum Jena, Jena, Germany
3Memorial Sloan Kettering Cancer Center, New York, NY
4National Cancer Center Hospital East, Kashiwa, Japan
5Hematology Department, Hôpital Saint-Louis, Paris, France
6HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, RIO DE JANEIRO/RJ, Brazil
7Novartis Pharma AG, Basel, Switzerland
8Novartis Institutes For Biomedical Research, Cambridge, MA
9South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia

10:45 AM

Andreas Hochhaus, MD1, Dong-Wook Kim, MD, PhD2, Jorge Cortes, MD3, Koji Sasaki, MD4, Michael Mauro, MD5, Timothy P Hughes, MD, MBBS, FRACP, FRCPA6, Massimo Breccia7*, Moshe Talpaz, MD8, Hironobu Minami, MD9*, Yeow Tee Goh, MBBS10, Daniel J. DeAngelo, MD11, Fabian Lang, MD12*, Michael C. Heinrich, MD13*, Valle Gomez G De Soria, MD14*, Philipp le Coutre, MD15*, Gessami Sanchez-Olle16*, Jomy Jose16*, Nathalie Pognan17*, Shruti Kapoor, MS18* and Delphine Rea, MD, PhD19

1Universitätsklinikum Jena, Jena, Germany
2Uijeongbu Eulji Medical Center, Uijeoungbu-si, Korea, Republic of (South)
3Georgia Cancer Center, Augusta University, Augusta, GA
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Memorial Sloan Kettering Cancer Center, New York, NY
6South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
7Department of Translational and Precision Medicine, Hematology-Sapienza University, Rome, Italy
8Division of Hematology-Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI
9Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
10Department of Hematology, Singapore General Hospital, Singapore, Singapore
11Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
12Hematology/Oncology, Klinikum der Goethe Universität, Frankfurt/Main, Germany
13Department of Medicine, Division of Hematology and Oncology, Portland VA Health Care System and Oregon Health & Science University, Knight Cancer Institute, Portland, OR
14Hospital de la Princesa, Madrid, Spain
15Charité-Universitätsmedizin Berlin, Berlin, Germany
16Novartis Pharma AG, Basel, Switzerland
17Global Drug Development, Novartis Pharma SAS, Rueil-Malmaison, France
18Novartis Pharmaceuticals Corporation, East Hanover, NJ
19Hematology Department, Hôpital Saint-Louis, Paris, France

*signifies non-member of ASH